Hamel Associates’s Kellanova K Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-11,688
Closed -$809K 84
2016
Q4
$809K Hold
11,688
0.42% 52
2016
Q3
$850K Hold
11,688
0.45% 50
2016
Q2
$896K Hold
11,688
0.46% 53
2016
Q1
$840K Hold
11,688
0.45% 55
2015
Q4
$793K Hold
11,688
0.51% 52
2015
Q3
$731K Sell
11,688
-453
-4% -$28.3K 0.52% 53
2015
Q2
$715K Sell
12,141
-1,065
-8% -$63.7K 0.47% 60
2015
Q1
$818K Hold
13,206
0.54% 60
2014
Q4
$811K Hold
13,206
0.53% 59
2014
Q3
$763K Hold
13,206
0.51% 60
2014
Q2
$815K Hold
13,206
0.54% 61
2014
Q1
$778K Buy
13,206
+8,413
+176% +$477K 0.54% 58
2013
Q4
$275K Buy
+4,793
New +$276K 0.19% 86

Other funds holding K

Hamel Associates's K Position: Q1 2017 in Review

Hamel Associates sold out of Kellanova (K) in Q1 2017, closing a stake of 11,688 shares — an estimated $809K sold.

Hamel Associates first reported a position in K in Q4 2013 and held it in 13 quarters. The position peaked at $896K in Q2 2016. 711 funds tracked by Wall St. Rank hold K as of Q1 2017.

  • Hamel Associates reported no remaining Kellanova position as of Q1 2017 after selling out during the quarter.
  • Hamel Associates sold 11,688 Kellanova shares in Q1 2017, an estimated $809K.
  • Hamel Associates first reported a position in Kellanova in Q4 2013 and held it in 13 quarters.
  • Hamel Associates's Kellanova position peaked at $896K in Q2 2016.
  • 711 funds tracked by Wall St. Rank held Kellanova as of Q1 2017.

Based on Hamel Associates's 13F filing for Q1 2017, filed 9 May 2017.